Workplace exposure to pesticides may boost a person’s risk of chronic obstructive pulmonary disease (COPD), a new study finds. COPD is a group of lung diseases that cause airflow blockage and breathing problems. Emphysema and chronic bronchitis are the two main types of COPD. According to the U.S. Centers for Disease Control and Prevention, it’s… read on > read on >
Two rheumatoid arthritis drugs show potential for lowering the risk of Parkinson’s disease, new research shows. Some previous studies have found that people with rheumatoid arthritis have a lower risk of Parkinson’s, and it was suggested that a class of rheumatoid arthritis drugs called disease-modifying antirheumatic drugs (DMARDs) may play a role in that reduced… read on > read on >
A robot performed challenging keyhole surgery on pigs without any human help in what could be a major step toward fully automated surgery on people. “Our findings show that we can automate one of the most intricate and delicate tasks in surgery: the reconnection of two ends of an intestine,” said senior study author Axel… read on > read on >
Red wine may be a guilty pleasure, but new research shows it might also be a powerful weapon against the ravages of Parkinson’s disease. Why? The antioxidants in red wine, and fruit such as berries for that matter, might slow progression of the movement disorder, a new study suggests. According to researchers, people with Parkinson’s… read on > read on >
THURSDAY, Jan. 27, 2022 (HealthDay News) — Taking vitamin D supplements may help stave off psoriasis, rheumatoid arthritis, lupus and other autoimmune diseases, a new study suggests. Previous research has hinted at this connection, but the new study is the first randomized controlled trial to look at what happens when people are given vitamin D… read on > read on >
Finding the right medication for rheumatoid arthritis isn’t easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms. The study was mandated by the U.S. Food and Drug Administration after earlier safety signals about the drug, called tofacitinib (Xeljanz).… read on > read on >
Allopurinol, a frequently used gout medication, does not appear to drive up the risk for dying among gout patients who also struggle with chronic kidney disease, new research shows. The finding is based on an analysis of two decades worth of British health records. And it may put to rest recent concerns regarding a well-known… read on > read on >
Belly fat is usually unwelcome, but new research suggests it may actually be good for something: relief from foot pain. A small pilot study suggests that an injection of a patient’s own fat cells can help ease the often-excruciating heel pain brought on by a condition known as plantar fasciitis. “We take a small amount… read on > read on >
TUESDAY, Jan. 25, 2022 (HealthDay News) – Older adults who maintain a steady weight as they age are less likely to experience rapid cognitive decline, regardless of how much they weigh to start, new research suggests. “There’s something about maintaining weight and BMI that seems to reflect some health resilience,” said study author Michal Schnaider… read on > read on >
MONDAY, Jan. 24, 2022 (healthDay News) — The U.S. Food and Drug Administration said Monday that it will curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant. The combo treatments bamlanivimab/etesevimab and casirivimab/imdevimab, made by Eli Lilly and Regeneron, respectively, performed well against earlier… read on > read on >
